Andia Redpath

Andia Redpath is a Research Fellow at the University of Oxford within the Department of Physiology, Anatomy and Genetics (DPAG). Supported by prestigious fellowships including the Oxford BHF CRE Basic Science Intermediate Transition Fellowship and John Fell OUP Research Fund, her research explores epicardial biology, cardiac inflammation, and regenerative strategies for cardiovascular diseases.

• BSc, MRes, PhD in Biochemistry and Biomedical Sciences from Imperial College London

Her work focuses on the cardiac mesothelium's role in immune responses and disease pathogenesis, particularly in conditions like systemic lupus erythematosus (SLE) and heart failure with reduced ejection fraction (HFrEF). She investigates how reprogramming mesothelial-immune interactions can dampen chronic inflammation and autoimmunity, supported by experts like Prof. Paul Riley and Prof. Nicola Smart.

Recent publications highlight her contributions to understanding heparan sulfate signaling, mesothelium-growth factor interactions, and vascular protection mechanisms. Her 2025 preprints on organ-specific gene regulation and SULF2 signaling in arthritis underscore her interdisciplinary approach bridging developmental biology and immunology.

Scientific awards include the BHF CRE Fellowship and NHLI Studentship. She actively supervises DPhil students and teaches cardiovascular regenerative medicine to undergraduates.